Retinal Vascular Disorders

The ophthalmology department at Profesorskie Centrum Medyczne Sp. z o.o. conducts trials aimed at improving visual acuity for patients with sight‑threatening retinal conditions by testing new anti‑VEGF alternatives and novel injection therapies.

  • Diabetic Macular Edema
  • Neovascular age‑related macular degeneration (nAMD)

Ongoing research seeks to provide safer and more effective options for individuals at risk of vision loss due to retinal vascular disease.

Thyroid Eye Disease (TED)

Clinical studies focus on moderate‑to‑severe active thyroid eye disease, evaluating innovative biologics and small‑molecule agents to reduce proptosis and improve ocular comfort.

  • Moderate-to-Severe Active Thyroid Eye Disease
  • Chronic Thyroid Eye Disease

The Gdańsk site offers open‑label access for participants who have not responded to existing therapies, advancing treatment possibilities for this disabling condition.

Uveitis and Inflammatory Eye Conditions

Trials investigate emerging immunomodulators for non‑infectious uveitis, targeting intermediate, posterior, and pan‑uveitis to control inflammation and preserve sight.

  • Active non‑infectious uveitis
  • Intermediate uveitis
  • Posterior uveitis
  • Panuveitis

Researchers assess safety and efficacy of these agents to offer new therapeutic pathways for patients with chronic ocular inflammation.

Acquired Blepharoptosis

A focused study evaluates topical treatments designed to correct acquired blepharoptosis, aiming for rapid functional improvement of eyelid position.

  • Acquired Blepharoptosis

The investigation explores convenient eye‑drop formulations that could replace more invasive surgical options.